Company accused of exploiting unique features of drug to retain market share
15 maart 2008
Doctors, governments, and drug regulators must watch the way drug companies operate because the dearth of new medicines is taking profit chasing to new heights, an expert has warned.
Bron: BMJ (registratie verplicht)
| < Vorige | Volgende > |
|---|
